Skip to content
CancerIndex

Publication

Interfacial lipid digestion-responsive injectable nanoemulsions enhance lapatinib efficacy in triple-negative breast cancer.

Nidhi Singh, Satyajit Halder, Alok Kumar, Rudra Chakravarti, Anubroto Pal, Dipanjan Ghosh, Pravat Kumar Parida, Anup Kumar Misra, Somendu Kumar Roy, Kuladip Jana, Pallab Datta

Colloids and surfaces. B, BiointerfacesDec 1, 2026PMID 42594794doi:10.1016/j.colsurfb.2026.116079 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 10, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260910-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Lapatinib (LPT), a brick-dust kinase inhibitor, shows slow oral bioavailability and dose-limiting gastrointestinal side effects that frequently lead to therapeutic discontinuation. Increasing oral bioavailability does not mitigate these adverse effects, and developing complex LPT delivery systems…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.